Validating a biosignature-predicting placebo pill response in chronic pain in the settings of a randomized controlled trial

Pain7.40
Volume: 163, Issue: 5, Pages: 910 - 922
Published: Aug 23, 2021
Abstract
In Brief The objective of this study is to validate a placebo pill response predictive model—a biosignature—that classifies chronic pain patients into placebo responders (predicted-PTxResp) and nonresponders (predicted-PTxNonR) and test whether it can dissociate placebo and active treatment responses. The model, based on psychological and brain functional connectivity, was derived in our previous study and blindly applied to current trial...
Paper Details
Title
Validating a biosignature-predicting placebo pill response in chronic pain in the settings of a randomized controlled trial
Published Date
Aug 23, 2021
Journal
Volume
163
Issue
5
Pages
910 - 922
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.